← Leaderboards
Dominick Auci
Therapyx, Inc.
$10,425,397
Attributed
$17,554,969
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,554,969 · 7
By mechanism
R44$13,938,979 · 4
SB1$3,000,000 · 1
R43$615,990 · 2
Top collaborators
- Michael W Russell9 shared
- Nejat K Egilmez6 shared
- Gerald W Dryden1 shared
Most similar at Therapyx, Inc.
Same institution · by research overlap
- Thomas F Conway$4,515,092
- Dominick L Auci$1,748,998
- Yingru Liu$3,653,041
Others in their field
Top investigators on “Formulation”
- David Heimbrook · Leidos Biomedical Research, Inc.$143,562,560
- Sharon A Nachman · Johns Hopkins University$135,132,510
- David W Simpson · University Of Southern California$88,046,235
- Jaap Goudsmit · Janessen Vaccines And Prevention, Bv$70,218,020
- Michael E Jackson · Unavco, Inc.$66,602,150
- Meghan Miller · Unavco, Inc.$66,602,150
Research focus
FormulationNovel TherapeuticsDrug KineticsToxicologyMeetingsMouse ModelDoseToxic EffectNonhuman PrimateCollaborationsDesignComparativePreparationBiological SciencesSmall Business Innovation Research GrantClinical TrialsFutureMonkeysRecommendationPharmaceutical PreparationsPrimatesParticleProductionBiological
Grant awards (20)
Therapy and Prophylaxis for Genital Tract Infection$1,000,000
SB1 · FY2025 · AI · contact PI
IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$959,868
R44 · FY2025 · DK · contact PI
Therapy and Prophylaxis for Genital Tract Infection$1,000,000
SB1 · FY2024 · AI · contact PI
IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$960,296
R44 · FY2024 · DK · contact PI
IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$1,201,534
R44 · FY2023 · DK · contact PI
Therapy and Prophylaxis for Genital Tract Infection$1,000,000
SB1 · FY2023 · AI · contact PI
Experimental Gonococcal Vaccine$1,000,000
R44 · FY2022 · AI · contact PI
Therapy and Prophylaxis for Genital Tract Infection$915,331
R44 · FY2022 · AI · contact PI
Therapy and Prophylaxis for Genital Tract Infection$1,000,000
R44 · FY2021 · AI · contact PI
Experimental Gonococcal Vaccine$1,000,000
R44 · FY2021 · AI · contact PI
IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$847,546
R44 · FY2021 · DK · contact PI
Therapy and Prophylaxis for Genital Tract Infection$1,000,000
R44 · FY2020 · AI · contact PI
IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$858,320
R44 · FY2020 · DK · contact PI
Experimental Gonococcal Vaccine$807,210
R44 · FY2020 · AI · contact PI
Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$999,998
R44 · FY2019 · AI · contact PI
IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis$388,880
R44 · FY2019 · DK · contact PI
Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$999,998
R44 · FY2018 · AI · contact PI
PLGA encapsulated polyphenols to ameliorate IBD.$320,159
R43 · FY2018 · AT · contact PI
Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD$999,998
R44 · FY2017 · AI · contact PI
Oral sustained-release IL-10 microspheres for therapy of IBD$295,831
R43 · FY2016 · DK · contact PI